Jordan 2011 GMP Guidelines for Medical Devices: ISO 13485 and Premises Approval

1. Key takeaways

The Jordanian Good Manufacturing Practice Guidelines for Medical Devices (2011) and ISO 13485 stand in a complementary rather than substitutive relationship. GRZAN’s conclusion is that the ISO 13485 certificate is a formal requirement for Jordanian registration, while the GMP guidelines describe the quality requirements of the manufacturing process — at review, both will be examined.

The second conclusion is that the remaining validity of the certificate is a hard indicator at formal screening. On the practical estimate applied by GRZAN, the red line is this: on the date the registration application is submitted in the electronic system, the manufacturer’s ISO 13485 certificate or country-of-origin GMP certificate must retain at least 6 months of validity; otherwise the application is highly likely to be returned outright at formal screening.

The third conclusion is that GMP is linked to premises approval. In the JFDA fee schedule, the premises approval fee is 700 JOD; the fee for issuance, renewal or scope extension of a GLP certificate is 1,000 JOD. Production-side compliance in Jordan is not a paper review but a matter that can trigger premises approval procedures.

• ISO 13485 is the formal ticket; the GMP guidelines are the substantive syllabus examined at review.
• Certificates must retain at least 6 months of validity on the submission date (practical estimate).
• Premises approval costs 700 JOD and a GLP certificate 1,000 JOD in the JFDA fee schedule.
• Renewed ISO 13485, CE or FDA certificates must be filed with JFDA through the AR.

2. Legal basis

The production-side requirements and their costs rest on the following instruments.

Provision numbers are subject to the Arabic original texts issued in the Jordanian Official Gazette and by JFDA; the amounts are the official fees listed in the JFDA fee schedule.

3. Expert insights

Insight 1: ISO 13485 is the admission ticket, the GMP guidelines the examination syllabus. At submission in Jordan, companies must provide a quality management system certificate (ISO 13485 or a country-of-origin GMP certificate). At technical review, JFDA examines the whole process against the GMP guidelines — design and development, purchasing, production control, inspection and testing, control of non-conforming product, corrective and preventive action, and management review. Holding an ISO 13485 certificate does not automatically satisfy the technical descriptions of the GMP guidelines. The distinction matters most when a certificate is old: the certificate proves the system exists, while the review tests whether the system, as documented, still matches the process that actually produces the device.

Insight 2: the six-month validity red line follows from the review cycle itself. The practical review cycle for Jordanian device registration is 4 to 8 months (about 4 months for Class I, about 4 to 8 months for Class IIb, about 8 months for Class III). If a certificate retains only 2 to 3 months of validity at submission, it will expire during the review, creating a state where the precondition lapses before the review concludes. The 6-month red line exists precisely to cover this cycle (practical estimate).

Insight 3: high-risk devices face a markedly higher probability of on-site inspection. Class III devices applying for the first time with complex production conditions have a relatively high probability of being scheduled for on-site inspection. Companies should ensure in advance that the quality management system operates effectively and that complete records are retained. Preparing for an inspection as if it were certain costs little; being unprepared when it arrives costs far more than the inspection itself.

Insight 4: certificate renewals require change filings. After a manufacturer’s ISO 13485, CE or FDA certificate is renewed or re-issued, an updated copy should be provided to JFDA through the AR. This is a continuing obligation that companies frequently overlook.

4. Practical recommendations

• Put certificate validity into the project schedule. Work backwards from the submission date and ensure that both the ISO 13485 certificate and the country-of-origin GMP certificate retain at least 6 months of validity; if not, renew first and submit later (practical estimate).
• Prepare self-inspection materials against the full process elements of the GMP guidelines. Records for the seven elements — design and development, purchasing, production control, inspection and testing, non-conforming product control, corrective and preventive action, and management review — should be retrievable at any time.
• Build a certificate register. Maintain expiry alerts for all certificates relied upon by valid Jordanian registrations, and complete updates and JFDA filings before expiry.
• Keep the fee schedule figures in the project budget at their current official values and re-check the schedule before each application, since fees are quoted in Jordanian dinars.

5. Verification checklist

• □ Confirm the ISO 13485 or country-of-origin GMP certificate retains at least 6 months of validity on the submission date (practical estimate)
• □ Complete a quality system self-inspection across the seven GMP elements and keep the records
• □ Confirm whether premises approval (700 JOD) or a GLP certificate (1,000 JOD) is required
• □ Confirm whether a high-risk device may trigger an on-site inspection and prepare the inspection materials
• □ Build a certificate expiry register and file renewals with JFDA through the AR without delay
• □ Keep the seven GMP element records indexed, so that any element can be produced within one working day when JFDA requests it
• □ Re-verify the cited provision numbers against the Arabic original texts of the Official Gazette

Regulatory information verified as of 29 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Jordanian market. Our team manages Jordan Food and Drug Administration (JFDA) registrations, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com